Boston Scientific Corporation (LON:0HOY)
102.02
+0.12 (0.11%)
At close: Jun 18, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
Other Revenue seg1 | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Revenue seg1 Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
MedSurg | 6.16B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
MedSurg Growth | 10.88% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiovascular | 11.40B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiovascular Growth | 24.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
MedSurg Income Before Taxes |
Log In |
Log In |
Log In |
Log In | Upgrade
|
MedSurg Income Before Taxes Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiovascular Income Before Taxes |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiovascular Income Before Taxes Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other EBT seg1 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other EBT seg1 Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
MedSurg Organic Revenue Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rhythm & Neuro Organic Revenue Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiovascular Organic Revenue Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|